...
机译:A ribonucleoprotein‐based decaplex CRISPR/Cas9 knockout strategy for CHO host engineering
Genentech, Inc.;
Large Molecule Research, Roche Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Roche Diagnostics GmbH;
CHO cells; CRISPR/Cas9; gRNA; multiplex knockout; ribonucleoprotein;